These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 6489667
1. [Effects of delayed-action metoprolol evaluated in hypertensive patients responsive to therapy subdivided in 2 different age groups]. Carpentiere G, Marino S, Castello F, Castello A, Cellura M. G Ital Cardiol; 1984 Jul; 14(7):530-3. PubMed ID: 6489667 [Abstract] [Full Text] [Related]
2. A comparative study of metoprolol and methyldopa in the treatment of hypertension. Karachalios GN. Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553 [Abstract] [Full Text] [Related]
3. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension. Comerford MB, Besterman EM. Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874 [Abstract] [Full Text] [Related]
4. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group. Hoffmann J. Blood Press Suppl; 1993 Feb; 1():30-6. PubMed ID: 8173688 [Abstract] [Full Text] [Related]
5. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol. Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I. Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699 [Abstract] [Full Text] [Related]
6. [Assessment of the efficacy and tolerance of delayed-action nifedipine as the monotherapy or in combination with metoprolol in patients with arterial hypertension]. Isaĭkina OIu, Gorbunov VM, Andreeva GF, Dmitrieva NA, Martsevich SIu. Ter Arkh; 2003 Sep; 75(12):39-43. PubMed ID: 14959468 [Abstract] [Full Text] [Related]
7. Metoprolol in hypertension: an open evaluation. Assaykeen TA, Michell G. Med J Aust; 1982 Jan 23; 1(2):73-7. PubMed ID: 7040924 [Abstract] [Full Text] [Related]
8. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group. Dahlöf B, Hosie J. Blood Press Suppl; 1993 Jan 23; 1():22-9. PubMed ID: 8173687 [Abstract] [Full Text] [Related]
9. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone. Dahlöf B, Jönsson L, Borgholst O, Ekblad G, Engstrand C, Grundestam I, Lindh A. Blood Press Suppl; 1993 Jan 23; 1():37-45. PubMed ID: 8173689 [Abstract] [Full Text] [Related]
10. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension. Logan RL, Goldstraw PW, Kiddle GB, Flacks LM, Watt M. N Z Med J; 1981 Jul 08; 93(687):1-2. PubMed ID: 7022275 [Abstract] [Full Text] [Related]
11. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups. Hosie J, Dahlöf B, Klein G. Blood Press Suppl; 1993 Jul 08; 1():46-50. PubMed ID: 8173690 [Abstract] [Full Text] [Related]
12. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules. Asplund J, Ohman P. Ann Clin Res; 1981 Jul 08; 13 Suppl 30():30-6. PubMed ID: 7027891 [Abstract] [Full Text] [Related]
13. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol. Lavenius B, Hansson L. Int J Clin Pharmacol Ther Toxicol; 1982 Jun 08; 20(6):291-5. PubMed ID: 7049966 [Abstract] [Full Text] [Related]
14. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT). Frishman WH, Hainer JW, Sugg J, M-FACT Study Group. Am J Hypertens; 2006 Apr 08; 19(4):388-95. PubMed ID: 16580575 [Abstract] [Full Text] [Related]
15. [Non-invasive long-term monitoring of blood pressure and arrhythmias in hypertensive patients treated with metoprolol]. Palma Gamiz JL, Codina J. Wien Med Wochenschr; 1988 Jan 31; 138(1-2):38-40. PubMed ID: 2451359 [Abstract] [Full Text] [Related]
16. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Liu J, Liu ZQ, Yu BN, Xu FH, Mo W, Zhou G, Liu YZ, Li Q, Zhou HH. Clin Pharmacol Ther; 2006 Jul 31; 80(1):23-32. PubMed ID: 16815314 [Abstract] [Full Text] [Related]
17. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents. Lyngstam O, Rydén L. Acta Med Scand; 1981 Jul 31; 209(4):261-6. PubMed ID: 7015797 [Abstract] [Full Text] [Related]
18. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group. Zanchetti A. Blood Press Suppl; 1995 Jul 31; 3():38-46. PubMed ID: 8535541 [Abstract] [Full Text] [Related]
19. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)]. Muiesan G, Agabiti-Rosei E, Buoninconti R, Carotti A, Fariello R, Innocenti P, Solinas E, Toso M, Motolese M. G Ital Cardiol; 1980 Jul 31; 10(11):1482-90. PubMed ID: 7202896 [Abstract] [Full Text] [Related]
20. Comparison of the antihypertensive effects of indapamide and metoprolol. Kubik MM, Coote JH. Postgrad Med J; 1981 Jul 31; 57 Suppl 2():44-50. PubMed ID: 7033946 [Abstract] [Full Text] [Related] Page: [Next] [New Search]